1. Home
  2. EVO vs FRBT Comparison

EVO vs FRBT Comparison

Compare EVO & FRBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$2.01

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Forbright Inc. Class A Common Stock

FRBT

Forbright Inc. Class A Common Stock

N/A

Current Price

$19.29

Market Cap

948.0M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
EVO
FRBT
Founded
1993
N/A
Country
Germany
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
948.0M
IPO Year
2007
2026

Fundamental Metrics

Financial Performance
Metric
EVO
FRBT
Price
$2.01
$19.29
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$7.00
N/A
AVG Volume (30 Days)
47.3K
138.3K
Earning Date
04-08-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$1.37
N/A
Revenue Next Year
$10.05
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.90
$17.72
52 Week High
$4.27
$22.00

Technical Indicators

Market Signals
Indicator
EVO
FRBT
Relative Strength Index (RSI) 41.66 51.98
Support Level $1.90 $18.40
Resistance Level $3.84 $21.15
Average True Range (ATR) 0.05 1.18
MACD 0.05 -0.07
Stochastic Oscillator 39.34 39.07

Price Performance

Historical Comparison
EVO
FRBT

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

About FRBT Forbright Inc. Class A Common Stock

Forbright Inc is a bank holding company. Along with its subsidiaries, it operates as a state chartered non-member bank, which serves the needs of individuals, small and medium sized businesses, and professional concerns. Its services include deposit and retail banking through a digital deposit platform, as well as financing and lending products such as lender finance loans, fund finance loans, healthcare finance loans, real estate loans, working capital facilities, warehouse lines of credit, and term loans.

Share on Social Networks: